When will Aurora Cannabis (ACB.TO stock) report earnings?

Aurora Cannabis (ACB.TO stock) reports on **04 Feb 2026** at **08:30 EST / 13:30 UTC**. Expect revenue, gross margin, and inventory commentary that could move the stock in pre-market and at the open.

What price target does Meyka AI have for ACB.TO stock?

Meyka AI's model projects a **yearly target of C$8.17** for ACB.TO stock. This implies a model-based upside of **+47.24%** versus the current price of **C$5.55**. Projections are not guarantees.

What are the main risks for ACB.TO stock after the earnings release?

Key risks for ACB.TO stock include continued negative EPS, high inventory days, weak retail demand, and any downgrade to guidance. Watch management comments for liquidity or restructuring signals.

How does ACB.TO stock compare to peers in the Healthcare sector?

ACB.TO stock trades at a low price-to-book near **0.55**, below sector averages. The stock appears cheaper than many peers, but valuation depends on sustainable margin and revenue growth.

CA Stocks

ACB.TO Aurora Cannabis (TSX) 04 Feb 2026 pre-market: earnings due, key forecast

ByHuzaifa Zahoor February 4, 2026February 4, 2026

ACB.TO stock is trading at C$5.55 pre-market as Aurora Cannabis Inc. prepares to report earnings on 04 Feb 2026. The company will release results at 08:30 EST / 13:30 UTC, and investors are watching cash, margins, and inventory after recent margin improvements. Today’s report should move the stock given the company’s C$313.99M market cap and elevated short-term trading volume.